• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Regulation of Iron Absorption and Homeostasis.铁吸收与稳态的调节
Clin Biochem Rev. 2016 May;37(2):51-62.
2
Regulation of iron metabolism by hepcidin.铁调素对铁代谢的调节作用。
Annu Rev Nutr. 2006;26:323-42. doi: 10.1146/annurev.nutr.26.061505.111303.
3
Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms.亚铁转运蛋白结合血红素肽的结构揭示了铁稳态的机制。
Nature. 2020 Oct;586(7831):807-811. doi: 10.1038/s41586-020-2668-z. Epub 2020 Aug 19.
4
Modelling Systemic Iron Regulation during Dietary Iron Overload and Acute Inflammation: Role of Hepcidin-Independent Mechanisms.饮食性铁过载和急性炎症期间系统性铁调节的模型构建:铁调素非依赖机制的作用
PLoS Comput Biol. 2017 Jan 9;13(1):e1005322. doi: 10.1371/journal.pcbi.1005322. eCollection 2017 Jan.
5
Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis.亚铁转运蛋白与铁调素的相互作用控制着全身铁稳态。
Int J Mol Sci. 2021 Jun 17;22(12):6493. doi: 10.3390/ijms22126493.
6
Regulation of the Iron Homeostatic Hormone Hepcidin.铁稳态激素铁调素的调节
Adv Nutr. 2017 Jan 17;8(1):126-136. doi: 10.3945/an.116.013961. Print 2017 Jan.
7
Biology of the iron efflux transporter, ferroportin.铁输出转运蛋白,铁蛋白的生物学。
Adv Protein Chem Struct Biol. 2021;123:1-16. doi: 10.1016/bs.apcsb.2020.10.005. Epub 2020 Dec 17.
8
Iron metabolism and iron disorders revisited in the hepcidin era.铁代谢与铁代谢紊乱:在铁调素时代的再认识
Haematologica. 2020 Jan 31;105(2):260-272. doi: 10.3324/haematol.2019.232124. Print 2020.
9
Erythroferrone: An Erythroid Regulator of Hepcidin and Iron Metabolism.红细胞铁调素:一种调节铁调素和铁代谢的红细胞调节因子。
Hemasphere. 2018 Mar 28;2(2):e35. doi: 10.1097/HS9.0000000000000035. eCollection 2018 Mar-Apr.
10
The liver in haemochromatosis.血色沉着病中的肝脏。
J Trace Elem Med Biol. 2015;31:219-24. doi: 10.1016/j.jtemb.2014.08.005. Epub 2014 Aug 21.

引用本文的文献

1
Unlocking iron: nutritional origins, metabolic pathways, and systemic significance.释放铁元素:营养来源、代谢途径及全身意义
Front Nutr. 2025 Aug 13;12:1637316. doi: 10.3389/fnut.2025.1637316. eCollection 2025.
2
Iron metabolism and ferroptosis in human health and disease.铁代谢与铁死亡在人类健康和疾病中的作用
BMC Biol. 2025 Aug 22;23(1):263. doi: 10.1186/s12915-025-02378-6.
3
Balancing Environmental Sustainability and Nutrition: Dietary Climate Impact in Relation to Micronutrient Intake and Status in a Swedish Cohort.平衡环境可持续性与营养:瑞典队列中饮食的气候影响与微量营养素摄入及状况的关系
Curr Dev Nutr. 2025 Jul 5;9(8):107501. doi: 10.1016/j.cdnut.2025.107501. eCollection 2025 Aug.
4
Phytochemicals as modulators of ferroptosis: a novel therapeutic avenue in cancer and neurodegeneration.植物化学物质作为铁死亡的调节剂:癌症和神经退行性疾病治疗的新途径。
Mol Biol Rep. 2025 Jun 25;52(1):636. doi: 10.1007/s11033-025-10752-4.
5
Drug Susceptibility, Siderophore Production, and Genome Analysis of Clinical Isolates from a University Hospital in Chiang Mai, Thailand.泰国清迈一家大学医院临床分离株的药敏性、铁载体产生及基因组分析
Antibiotics (Basel). 2025 May 18;14(5):521. doi: 10.3390/antibiotics14050521.
6
Association Between Body Iron Status and Biological Aging.身体铁状态与生物衰老之间的关联
Nutrients. 2025 Apr 23;17(9):1409. doi: 10.3390/nu17091409.
7
Lactoferrin-A Regulator of Iron Homeostasis and Its Implications in Cancer.乳铁蛋白——铁稳态的调节因子及其在癌症中的意义
Molecules. 2025 Mar 28;30(7):1507. doi: 10.3390/molecules30071507.
8
Pro-inflammatory Cytokines, Ferroptosis, and Cancer.促炎细胞因子、铁死亡与癌症
Acta Naturae. 2025 Jan-Mar;17(1):4-10. doi: 10.32607/actanaturae.27547.
9
A causal inference study exploring the impact of iron status on the risk of thyroid cancer based on two-sample mendelian randomization.一项基于两样本孟德尔随机化法探究铁状态对甲状腺癌风险影响的因果推断研究。
Discov Oncol. 2025 Apr 7;16(1):485. doi: 10.1007/s12672-025-02270-3.
10
L-Arginine and Nitric Oxide in Vascular Regulation-Experimental Findings in the Context of Blood Donation.血管调节中的L-精氨酸与一氧化氮——献血背景下的实验发现
Nutrients. 2025 Feb 13;17(4):665. doi: 10.3390/nu17040665.

本文引用的文献

1
The global prevalence of HFE and non-HFE hemochromatosis estimated from analysis of next-generation sequencing data.根据对下一代测序数据的分析估计的HFE和非HFE血色素沉着症的全球患病率。
Genet Med. 2016 Jun;18(6):618-26. doi: 10.1038/gim.2015.140. Epub 2015 Dec 3.
2
Endofin, a novel BMP-SMAD regulator of the iron-regulatory hormone, hepcidin.Endofin,一种铁调节激素(铁调素)的新型骨形态发生蛋白 - SMAD调节剂。
Sci Rep. 2015 Sep 11;5:13986. doi: 10.1038/srep13986.
3
Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia.在β地中海贫血小鼠模型中,促红细胞生成素铁调素有助于抑制铁调素并导致铁过载。
Blood. 2015 Oct 22;126(17):2031-7. doi: 10.1182/blood-2015-07-658419. Epub 2015 Aug 14.
4
Next-generation sequencing: Application of a novel platform to analyze atypical iron disorders.下一代测序:新型平台在分析非典型铁代谢紊乱中的应用。
J Hepatol. 2015 Nov;63(5):1288-93. doi: 10.1016/j.jhep.2015.06.027. Epub 2015 Jul 4.
5
SLC39A14 Is Required for the Development of Hepatocellular Iron Overload in Murine Models of Hereditary Hemochromatosis.SLC39A14是遗传性血色素沉着症小鼠模型中肝细胞铁过载发展所必需的。
Cell Metab. 2015 Jul 7;22(1):138-50. doi: 10.1016/j.cmet.2015.05.002. Epub 2015 May 28.
6
Macrophages and iron trafficking at the birth and death of red cells.红细胞生成与死亡过程中的巨噬细胞及铁转运
Blood. 2015 May 7;125(19):2893-7. doi: 10.1182/blood-2014-12-567776. Epub 2015 Mar 16.
7
Analysis of IL-22 contribution to hepcidin induction and hypoferremia during the response to LPS in vivo.体内对脂多糖反应过程中白细胞介素-22对铁调素诱导和低铁血症作用的分析。
Int Immunol. 2015 Jun;27(6):281-7. doi: 10.1093/intimm/dxu144. Epub 2015 Jan 7.
8
A critical role for murine transferrin receptor 2 in erythropoiesis during iron restriction.铁限制期间小鼠转铁蛋白受体2在红细胞生成中的关键作用。
Br J Haematol. 2015 Mar;168(6):891-901. doi: 10.1111/bjh.13225. Epub 2014 Nov 17.
9
Effect of the antihepcidin Spiegelmer lexaptepid on inflammation-induced decrease in serum iron in humans.抗铁调素 Spiegelmer 药物 lexaptepid 对炎症诱导的人体血清铁降低的影响。
Blood. 2014 Oct 23;124(17):2643-6. doi: 10.1182/blood-2014-03-559484. Epub 2014 Aug 27.
10
BMP type II receptors have redundant roles in the regulation of hepatic hepcidin gene expression and iron metabolism.骨形态发生蛋白II型受体在肝脏铁调素基因表达和铁代谢的调节中具有冗余作用。
Blood. 2014 Sep 25;124(13):2116-23. doi: 10.1182/blood-2014-04-572644. Epub 2014 Jul 29.

铁吸收与稳态的调节

The Regulation of Iron Absorption and Homeostasis.

作者信息

Wallace Daniel F

机构信息

QIMR Berghofer Medical Research Institute, Brisbane, Queensland, 4006 Australia.

出版信息

Clin Biochem Rev. 2016 May;37(2):51-62.

PMID:28303071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5198508/
Abstract

Iron is an essential element in biology, required for numerous cellular processes. Either too much or too little iron can be detrimental, and organisms have developed mechanisms for balancing iron within safe limits. In mammals there are no controlled mechanisms for the excretion of excess iron, hence body iron homeostasis is regulated at the sites of absorption, utilisation and recycling. This review will discuss the discoveries that have been made in the past 20 years into advancing our understanding of iron homeostasis and its regulation. The study of iron-associated disorders, such as the iron overload condition hereditary haemochromatosis and various forms of anaemia have been instrumental in increasing our knowledge in this area, as have cellular and animal model studies. The liver has emerged as the major site of systemic iron regulation, being the location where the iron regulatory hormone hepcidin is produced. Hepcidin is a negative regulator of iron absorption and recycling, achieving this by binding to the only known cellular iron exporter ferroportin and causing its internalisation and degradation, thereby reducing iron efflux from target cells and reducing serum iron levels. Much of the research in the iron metabolism field has focussed on the regulation of hepcidin and its interaction with ferroportin. The advances in this area have greatly increased our knowledge of iron metabolism and its regulation and have led to the development of novel diagnostics and therapeutics for iron-associated disorders.

摘要

铁是生物学中的一种必需元素,众多细胞过程都需要它。铁过多或过少都可能有害,生物体已形成在安全范围内平衡铁的机制。在哺乳动物中,没有控制多余铁排泄的机制,因此机体铁稳态在吸收、利用和再循环部位进行调节。本综述将讨论过去20年中在增进我们对铁稳态及其调节的理解方面所取得的发现。对与铁相关疾病的研究,如铁过载疾病遗传性血色素沉着症和各种形式的贫血,以及细胞和动物模型研究,都有助于增加我们在这一领域的知识。肝脏已成为全身铁调节的主要部位,是产生铁调节激素铁调素的地方。铁调素是铁吸收和再循环的负调节因子,它通过与唯一已知的细胞铁输出蛋白铁转运蛋白结合,使其内化和降解,从而减少铁从靶细胞的外流并降低血清铁水平。铁代谢领域的许多研究都集中在铁调素的调节及其与铁转运蛋白的相互作用上。这一领域的进展极大地增加了我们对铁代谢及其调节的认识,并导致了针对与铁相关疾病的新型诊断方法和治疗方法的开发。